comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 12:35:28 - browse：859

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Eye stem cell transplant could help restore vision in injured people

focus

WSS

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

FDA approves first treatment for ultra

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Study identifies new proteins linked to dementia risk 25 years later

Congress must give Medicare recipients genetic counseling access

7 more heat

Wikipedia

comprehensive

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Awakening the world to the whoosh: A patient's crusade

Wildfire smoke exposes gaps in outdoor worker protections

The pain doctors face in trying to build their families

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stanford president's case begs question: Who takes blame?

Dobbs anniversary: the lost opportunity of abortion as health care

Judge rejects Trump's request to move Stormy Daniels hush

Medicare proposal to cover medical devices draws a mixed reaction

7 more heat

leisure time

Vir antibody drug aimed at influenza A fails in clinical trial

Driven by the pandemic, applicants flood public health schools

Eye stem cell transplant could help restore vision in injured people

Listen: Racing for gene therapy & a pioneering approval

Indian pharmaceutical industry in denial over drug

Clinical trials must include more disabled people

leisure time

Wikipedia

focus

entertainment